Current Report Filing (8-k)
September 04 2019 - 05:25PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): September 4, 2019
SIGMA
LABS, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
001-38015
|
|
27-1865814
|
(State
or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code: (505) 438-2576
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
|
SGLB
|
|
The
NASDAQ Stock Market LLC
|
Warrants
to Purchase Common Stock, par value $0.001 per share
|
|
SGLBW
|
|
The
NASDAQ Stock Market LLC
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth
company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
As
previously disclosed, on April 8, 2019, Sigma Labs, Inc. (“we,” “our,” “us,” or the “Company”)
received a letter from Nasdaq notifying us that we were no longer in compliance with the minimum stockholders’ equity requirement
for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital
Market to maintain stockholders’ equity of at least $2,500,000. In the Company’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2018, the Company reported stockholders’ equity of $1,735,439, which is below the minimum
stockholders’ equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1). Further, as of April 8,
2019, the Company did not meet the alternative Nasdaq continued listing standards relating to the market value of listed securities
or net income from continuing operations.
On
August 2, 2019, we closed an underwritten public offering of 2,875,000 shares of our common stock at a price of $0.80 per share,
resulting in gross proceeds of $2,300,000 (the “Offering”). As a result of the Offering, the Company believes it has
regained compliance with the stockholders’ equity requirement, and therefore satisfies the applicable requirement for continued
listing on The Nasdaq Capital Market. Nasdaq will continue to monitor the Company’s
ongoing compliance with the stockholders’ equity requirement and, if upon the filing
of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 the Company does not evidence compliance,
it may be subject to delisting.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
September 4, 2019
|
SIGMA
LABS, INC.
|
|
|
|
By:
|
/s/
John Rice
|
|
Name:
|
John
Rice
|
|
Title:
|
President
and Chief Executive Officer
|
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sigma Labs (NASDAQ:SGLB)
Historical Stock Chart
From Mar 2023 to Mar 2024